Acquisition includes abelacimab, a Factor XI-inhibiting monoclonal antibody in development for stroke prevention in patients ...

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...

Wexford is partnering with Atrium Health to build The Pearl, a $1.5 billion innovative district that broke ground in 2023.

In 2024, the city passes an ordinance that requires rehabilitation clinics to be 500 feet away from existing ones and from ...

A Bakersfield hospital Monday became the first in Kern County to successfully implant the AVEIR DR, the world's first dual-chamber leadless pacemaker system from Abbott that treats people with ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody ...

Roman Harner said the first Monday of February was the Volstead Act’s worst day in the 13 years the bar has served downtown ...

Novartis to buy Boston-based clinical-stage biopharma company, Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced tha ...

The HYPERION study will be stopped early due to positive efficacy data from across the sotatercept clinical program.

“Therefore, it is paramount that clinicians make the right choices ... and on the development of more effective catheter ablation techniques for patients with persistent atrial fibrillation.” ...

The pharmaceutical giant said it has agreed to acquire the U.S. privately held, clinical-stage biopharmaceutical company to ...